author-photo

Montserrat Arumi

Pompeu Fabra University

9

Papers

65

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Prognostic value of stem cell markers in glioblastoma

2019 Biomarkers
Show All
- Source
- Cite
- Save
Citations (3)
MET in small cell lung carcinoma (SCLC): Effects of a MET inhibitor in SCLC cell lines and prognostic role of MET status in patients

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array study.

2012 Cancer Genetics and Cytogenetics
Show All
- Source
- Cite
- Save
Citations (11)
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients

2010 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (25)
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors

2009 Breast Cancer Research
Show All
- Source
- Cite
- Save
Citations (20)